Infectious Diseases Market in US 2015-2019

1
Infectious Diseases Market in US 2015-2019
Single User License - 3000 Site User
License - 3500 Corporate User License -
4500 Publication Date - Jun 2015 Pages -
111 To know more details, email to
debora_at_reportstack.com
2
Summary

• Human beings are prone to various kinds of
  infections. Infectious diseases are caused by
  various pathogenic microorganisms such as
  bacteria, fungi, parasites, and viruses.
  Antimicrobials are used to treat infections. They
  act by killing or resisting the growth of the
  microorganisms. They either act via the host
  defense system or directly target the causative
  agent. Based on the target organism,
  antimicrobials can be classified into
  anti-bacterial, anti-viral, anti-fungal, and
  anti-parasitic drugs.
• The analysts forecast the infectious diseases
  market in US to grow at a CAGR of 3.37 over the
  period 2014-2019.

3
Key vendors
F. Hoffmann-La Roche Gilead Sciences
GlaxoSmithKline Johnson Johnson Merck
Pfizer
4
Other Prominent Vendors
AbbVie Astellas Pharma AstraZeneca
Bayer Bristol-Myers Squibb Chimerix
Pharmaceuticals Cubist Eli Lilly Isis
Pharmaceuticals Mitsubishi Tanabe Pharma
Novartis Sanofi Vertex 
5
Key Questions Answered in this Report
What will the market size be in 2019 and what
will the growth rate be? What are the key
market trends? What is driving this market?
What are the challenges to market growth? Who
are the key vendors in this market space? What
are the market opportunities and threats faced by
the key vendors? What are the strengths and
weaknesses of the key vendors?
6
If you are interested...
Contact Debora White Email
debora_at_reportstack.com Ph1-888-789-6604 http/
/www.reportstack.com